Related Experiment Video
Updated: Aug 8, 2025

Standardized Colon Ascendens Stent Peritonitis in Rats - a Simple, Feasible Animal Model to Induce Septic Acute Kidney Injury
Published on: February 15, 2022
Stimulation of angiotensin II type 2 receptor attenuates organ injury in rats with polymicrobial sepsis
Chih-Chin Shih1, Shiu-Jen Chen2, Wen-Kuei Chang3,4
1Department of Pharmacology, National Defense Medical Center, Taipei, Taiwan, ROC.
Background:
Both inflammation and oxidative stress contribute to the pathogenesis of sepsis and its associated organ damage. Angiotensin-(1-7), acting through the Mas receptor and angiotensin II-type 2 receptors (AT2R), could attenuate organ dysfunction and improve survival in rats with sepsis. However, the role of AT2R in inflammation and oxidative stress in rats with sepsis is unclear. Therefore, this study examined the modulatory effects and molecular mechanism of AT2R stimulation in rats with polymicrobial sepsis.
Methods:
Male Wistar rats underwent cecal ligation and puncture (CLP) or sham surgery followed by the administration of saline or CGP42112 (a selective, high-affinity agonist of AT2R, 50 μg/kg intravenously) at 3 hours after sham surgery or CLP. The changes in hemodynamics, biochemical variables, and plasma levels of chemokines and nitric oxide were detected during the 24-hour observation. Organ injury was evaluated by histological examination.
Results:
We found that CLP evoked delayed hypotension, hypoglycemia, and multiple organ injuries, characterized by elevated plasma biochemical parameters and histopathological changes. These effects were attenuated by treatment with CGP42112. CGP42112 significantly attenuated plasma chemokines and nitric oxide production and reduced liver inducible nitric oxide synthase and nuclear factor kappa-B expression. More importantly, CGP42112 significantly improved the survival of rats with sepsis (50% vs. 20% at 24 h after CLP, p < 0.05).
Conclusion:
The protective effects of CGP42112 may be related to anti-inflammatory responses, suggesting that the stimulation of AT2R is a promising therapeutic candidate for the treatment of sepsis.
Insights
Stimulating angiotensin II-type 2 receptors (AT2R) with CGP42112 improved survival in septic rats. This treatment reduced inflammation and organ damage, suggesting AT2R stimulation is a promising sepsis therapy.
Area of Science:
- Cardiovascular Biology
- Inflammation and Immunology
- Renal Physiology
Background:
- Sepsis pathogenesis involves inflammation and oxidative stress, leading to organ damage.
- Angiotensin-(1-7) via Mas and angiotensin II-type 2 receptors (AT2R) may protect against sepsis-induced organ dysfunction.
- The specific role of AT2R in sepsis-related inflammation and oxidative stress remains unclear.
Purpose of the Study:
- To investigate the modulatory effects of AT2R stimulation on inflammation and oxidative stress in a rat model of polymicrobial sepsis.
- To elucidate the molecular mechanisms underlying AT2R's protective actions in sepsis.
Main Methods:
- Male Wistar rats underwent cecal ligation and puncture (CLP) or sham surgery.
- Rats received intravenous saline or CGP42112 (AT2R agonist) 3 hours post-surgery.
- Hemodynamics, biochemical markers, chemokine/nitric oxide levels, and organ histology were assessed over 24 hours.
Main Results:
- CLP induced hypotension, hypoglycemia, and organ injury, evidenced by altered biochemical and histological parameters.
- CGP42112 treatment attenuated these sepsis-induced effects.
- CGP42112 reduced plasma chemokines and nitric oxide, decreased liver inducible nitric oxide synthase and nuclear factor-kappaB expression, and improved survival rates (50% vs. 20% at 24h).
Conclusions:
- AT2R stimulation with CGP42112 demonstrated significant protective effects in a rat model of sepsis.
- These benefits are likely mediated by anti-inflammatory actions.
- Targeting AT2R represents a promising therapeutic strategy for managing sepsis.
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Acute Kidney Injury II: Pathophysiology

